February « 2023 « Science and Enterprise

Bio-Electric Regeneration Company Adds $8M in Seed Funds

By Alan, on February 16th, 2023%

A start-up enterprise, spun-off from Tufts University labs, creating bio-electrical treatments for regenerating limbs and tissue, is raising $8 million in new seed funds. . . . → Read More: Bio-Electric Regeneration Company Adds $8M in Seed Funds

Quantum, AI Systems Company Gains $500M in New Funds

By Alan, on February 15th, 2023%

A developer of systems with quantum computing and artificial intelligence as a service, initially for security applications, is raising $500 million in new venture funds. . . . → Read More: Quantum, AI Systems Company Gains $500M in New Funds

Biotech Drug Shown to Kill Prostate Tumor Cells

By Alan, on February 14th, 2023%

Tests with lab mice show low doses of an experimental oral drug can selectively kill prostate cancer cells while not affecting surrounding healthy tissue. . . . → Read More: Biotech Drug Shown to Kill Prostate Tumor Cells

Nasal Spray Reduces Flu Duration in Challenge Trial

By Alan, on February 13th, 2023%

An influenza vaccine given as a nasal spray is shown in a clinical trial to reduce the amount of time participants have flu infections, when exposed to the virus. . . . → Read More: Nasal Spray Reduces Flu Duration in Challenge Trial

Infographic – The Earth’s Converging Plates

By Alan, on February 11th, 2023%

Among the forces beneath the earth’s surface are the movements of tectonic plates, large shifting and sliding slabs of rock, where at their boundaries most earthquakes and volcanoes occur. . . . → Read More: Infographic – The Earth’s Converging Plates

Clinical Trial Underway Testing Influenza Vaccine Patch

By Alan, on February 10th, 2023%

A clinical trial has begun testing a commercially-available flu vaccine administered with a painless patch device against conventional syringe injection delivery. . . . → Read More: Clinical Trial Underway Testing Influenza Vaccine Patch

Green Energy Chemical Company Starts-Up, Raises $15M

By Alan, on February 9th, 2023%

A new enterprise, spun-off from labs at Northwestern University, says it’s designing electrochemical processes and systems for nanoscale materials to help meet the climate crisis. . . . → Read More: Green Energy Chemical Company Starts-Up, Raises $15M

Data Support Placebo Group Alternatives in Rare Disease Trials

By Alan, on February 8th, 2023%

Findings from a review of medical data and records indicate matched genetic control groups may not be needed in clinical trials testing treatments for Duchenne muscular dystrophy. . . . → Read More: Data Support Placebo Group Alternatives in Rare Disease Trials

AI-Aided Mobile App Shown to Screen for Melanoma

By Alan, on February 7th, 2023%

The developer of an app using algorithms to analyze images of skin lesions says clinical trial findings show the system detects melanoma more reliably than some physicians. . . . → Read More: AI-Aided Mobile App Shown to Screen for Melanoma

Allergy Antibody Biotech Gains $40M in New Funds

By Alan, on February 6th, 2023%

A biotechnology enterprise creating engineered antibodies to treat severe food allergies is raising $40 million in its second venture financing round. . . . → Read More: Allergy Antibody Biotech Gains $40M in New Funds

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise